News Release Details

Opiant Pharmaceuticals to Participate in 32nd Oppenheimer Healthcare Conference

March 10, 2022 at 4:01 PM EST

SANTA MONICA, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that its Chief Executive Officer, Dr. Roger Crystal, will participate in a fireside chat at the 32nd Annual Oppenheimer Healthcare Conference taking place virtually March 15 - March 17. Management will also host investor 1x1 meetings.

32nd Oppenheimer Annual Oppenheimer Healthcare Conference
March 15 – 17, 2022
Fireside chat on March 16 at 2:40 pm ET; hosting 1-on-1 meetings

A webcast of the presentation will be accessible on the Opiant website.

About Opiant Pharmaceuticals, Inc. 
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: and follow Opiant on Twitter (@Opiant_Pharma).

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410 

Primary Logo

Source: Opiant Pharmaceuticals, Inc.